- Over the past 100 years, equities have shown positive returns over a decade, making stocks a good investment for competitive returns until 2036. Dividend stocks, like Bristol Myers Squibb and Amgen, offer even better returns with dividend reinvestment.
- Bristol Myers Squibb has a strong product lineup, including oncology treatments and novel compounds like BMS-986446 for Alzheimer’s disease. Despite recent challenges, the company is expected to launch new products, maintain its dividend program, and see growth.
- Amgen faces a patent cliff but has strong growth drivers like Tezspire and Repatha. With a robust pipeline and a history of dividend increases, Amgen is positioned for success over the next decade. Investors can confidently add this stock to their portfolios.
Read more at Nasdaq: 2 Dividend Stocks to Buy and Hold For 10 Years